Pertuzumab with Trastuzumab and Docetaxel in Elderly Patients in the CLEOPATRA Study


Pertuzumab with Trastuzumab and Docetaxel in Elderly Patients in the CLEOPATRA Study
Slides from a presentation at SABCS 2012 and transcribed comments from recent interviews with Edith A Perez, MD (1/17/13) and Kimberly L Blackwell, MD (1/8/13)
Miles D et al. Pertuzumab (P) in combination with trastuzumab (T) and docetaxel (D) in elderly patients with HER2-positive metastatic breast cancer in the CLEOPATRA study. San Antonio Breast Cancer Symposium 2012;Abstract P5-18-01.
Dr Blackwell is Professor of Medicine and Director of the Breast Cancer Program at Duke Cancer Institute in Durham, North Carolina.

Dr Perez is Deputy Director at Large of the Mayo Clinic Cancer Center, Group Vice Chair of the Alliance of Clinical Trials in Oncology and Serene M and Frances C Durling Professor of Medicine at the Mayo Clinic in Jacksonville, Florida.